Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (42)

2016

  1. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

    Journal of Neurology, Vol. 263, Núm. 5, pp. 895-905

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

  2. Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension

    Journal of Human Hypertension, Vol. 29, Núm. 10, pp. 604-609

  3. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

    Parkinsonism and Related Disorders, Vol. 21, Núm. 5, pp. 494-499

  4. Exploring genetic factors involved in huntington disease age of onset: E2F2 as a new potential modifier gene

    PLoS ONE, Vol. 10, Núm. 7

2013

  1. Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)

    Neurologia, Vol. 28, Núm. 8, pp. 503-521

  2. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

    Parkinsonism and Related Disorders, Vol. 19, Núm. 10, pp. 906-909

  3. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene

    Parkinsonism and Related Disorders, Vol. 19, Núm. 1, pp. 95-100

  4. Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II

    Neurologia, Vol. 28, Núm. 9, pp. 558-583

  5. Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: Are they related?

    Journal of Neurology, Vol. 260, Núm. 7, pp. 1752-1756

  6. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease

    Clinical Neurology and Neurosurgery, Vol. 115, Núm. 8, pp. 1230-1233

2012

  1. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy

    Parkinsonism and Related Disorders, Vol. 18, Núm. 1, pp. 45-48

2011

  1. Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease

    Journal of Neurology, Vol. 258, Núm. 3, pp. 494-499

  2. Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)

    Journal of the Neurological Sciences, Vol. 310, Núm. 1-2, pp. 86-89

  3. Relationship between sleep and dysautonomic symptoms assessed by self-report scales

    Movement Disorders

2010

  1. Bomba de apomorfina: Inconvenientes

    Revista de Neurologia, Vol. 50, Núm. SUPPL. 1

  2. Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the α-synuclein gene (SNCA)

    Clinical Autonomic Research, Vol. 20, Núm. 4, pp. 267-269

  3. Complicaciones del tratamiento en la enfermedad de Parkinson. Las fluctuaciones con síntomas no motores

    Revista de Neurologia, Vol. 50, Núm. SUPPL. 4

  4. Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69

  5. Factors influencing the symmetry of Parkinson's disease symptoms

    Clinical Neurology and Neurosurgery, Vol. 112, Núm. 4, pp. 302-305